瑞马唑仑的临床研究进展  

Progress in clinical research on remazolam

作　　者：忻钰棋 曹亚[2] 王玉龙 XIN Yuqi;CAO Ya;WANG Yulong(School of Anesthesiology,Wannan Medical College,Wuhu 241000,Anhui,China;Department of Anesthesiology,Yijishan Hospital,Wannan Medical College,Wuhu 241000,Anhui,China)

机构地区：[1]安徽芜湖皖南医学院麻醉学院,安徽芜湖241000 [2]安徽芜湖皖南医学院弋矶山医院麻醉科,安徽芜湖241000

出　　处：《中国临床药理学与治疗学》2023年第10期1195-1200,共6页Chinese Journal of Clinical Pharmacology and Therapeutics

基　　金：2022年皖南医学院中青年科研基金项目(WK2022F03)。

摘　　要：苯二氮卓类药物是麻醉领域最常用的药物之一。瑞马唑仑是一种新开发的超短效苯二氮卓类药,它具有起效快、恢复快、安全性高等特点,并且低血压、呼吸抑制等副作用少。本综述旨在概述瑞马唑仑的药代动力学、临床药理学作用机制和临床应用的研究进展。Benzodiazepines are among the most commonly used drugs in the field of anesthesia.Remazolam is a newly developed ultra-short-acting benzodiazepine,which has the characteristics of rapid onset,rapid recovery,high safety,and less side effects such as hypotension and respiratory depression.The aim of this review is to summarize the progress of pharmacokinetics,clinical pharmacology mechanism of action and clinical application of remazolam.

关 键 词：瑞马唑仑 超短效苯二氮卓类药 镇静剂 

分 类 号：R614[医药卫生—麻醉学]